flutamide has been researched along with Neoplasms in 7 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The in vitro anticancer studies showed that the conjugates of flutamide are more active than the free flutamide and the flutamide derivatives, thus diminishing the amount of flutamide used." | 1.48 | Anticancer Activity of Resorcinarene-PAMAM-Dendrimer Conjugates of Flutamide. ( Cortez-Maya, S; Hernández-Ortega, S; Martínez-García, M; Martínez-Klimov, ME; Martínez-Klimova, E; Pedro-Hernández, LD; Ramírez-Ápan, T; Vargas-Medina, AC, 2018) |
| "Imaging of tumors with a cooled charge-coupled device camera revealed that the response of AdTSTA to flutamide is more sensitive and robust than serum PSA measurements." | 1.33 | Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model. ( Carey, M; Gambhir, SS; Ilagan, R; Iyer, M; Le, K; Pottratz, J; Salas, S; Wu, L; Zhang, LJ, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, HR | 1 |
| Abraham, DJ | 1 |
| Diamandis, P | 1 |
| Wildenhain, J | 1 |
| Clarke, ID | 1 |
| Sacher, AG | 1 |
| Graham, J | 1 |
| Bellows, DS | 1 |
| Ling, EK | 1 |
| Ward, RJ | 1 |
| Jamieson, LG | 1 |
| Tyers, M | 1 |
| Dirks, PB | 1 |
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Pedro-Hernández, LD | 1 |
| Martínez-Klimova, E | 1 |
| Martínez-Klimov, ME | 1 |
| Cortez-Maya, S | 1 |
| Vargas-Medina, AC | 1 |
| Ramírez-Ápan, T | 1 |
| Hernández-Ortega, S | 1 |
| Martínez-García, M | 1 |
| O'Rourke, ME | 1 |
| Ruble, K | 1 |
| Ilagan, R | 1 |
| Zhang, LJ | 1 |
| Pottratz, J | 1 |
| Le, K | 1 |
| Salas, S | 1 |
| Iyer, M | 1 |
| Wu, L | 1 |
| Gambhir, SS | 1 |
| Carey, M | 1 |
| Rochat, B | 1 |
| Morsman, JM | 1 |
| Murray, GI | 1 |
| Figg, WD | 1 |
| McLeod, HL | 1 |
1 review available for flutamide and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
6 other studies available for flutamide and Neoplasms
| Article | Year |
|---|---|
Identification of a lead pharmacophore for the development of potent nuclear receptor modulators as anticancer and X syndrome disease therapeutic agents.
Topics: Antineoplastic Agents; Cell Line; Chemistry, Pharmaceutical; Chenodeoxycholic Acid; DNA-Binding Prot | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
Anticancer Activity of Resorcinarene-PAMAM-Dendrimer Conjugates of Flutamide.
Topics: Antineoplastic Agents; Apoptosis; Calixarenes; Cell Line, Tumor; Cell Proliferation; Dendrimers; Dru | 2018 |
Addressing bone loss in the cancer survivor.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Density; Female; Flutamide; Huma | 2009 |
Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model.
Topics: Adenoviridae; Androgens; Animals; Antineoplastic Agents, Hormonal; Binding Sites; Chromatin Immunopr | 2005 |
Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aryl Hydrocarbon Hydroxylases; Biotransforma | 2001 |